Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

PHASE3CompletedINTERVENTIONAL

Enrollment

626

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Allergic RhinitisSeasonal Allergic Rhinitis

Interventions

DRUG

Fluticasone propionate

Nasal spray formulation (200 mcg/day)

DRUG

Placebo

Vehicle for Fluticasone propionate aqueous nasal spray

Trial Locations (1)

PPD Corporate Headquarters, Wilmington